Bayarak Elesin
Cancer is a highly complex and heterogeneous disease, where the
genetic landscape and cellular makeup of tumors exhibit vast variation not only
between patients but also within a single tumor. This heterogeneity contributes
to challenges in diagnosis, treatment response, and the development of
therapeutic resistance. Traditional bulk genomic sequencing approaches, which
analyze average gene expression or mutation profiles from a large collection of
cells, often fail to capture the diversity of the Tumor Microenvironment (TME) or
reflect the interactions between different cell populations within a tumor.
Share this article
Journal of Clinical & Medical Genomics received 391 citations as per Google Scholar report